Atezolizumab
Products Atezolizumab was approved as an infusion product in the United States in 2016 and in the EU and many countries in 2017 (Tecentriq). Structure and properties Atezolizumab is a humanized IgG1κ monoclonal antibody with a molecular mass of 145 kDa. Effects Atezolizumab (ATC L01XC32) has immunostimulatory and antitumor properties. The effects are due to … Atezolizumab